Decoy Therapeutics (DCOY) Short-term Investments (2015 - 2018)

Decoy Therapeutics (DCOY) has reported Short-term Investments for 4 consecutive years, with $2.0 million the latest figure, recorded in Q1 2018.

• In Q1 2018, Short-term Investments fell 93.7% year-over-year to $2.0 million; the TTM figure through Mar 2018 stood at $2.0 million (down 93.7% YoY), while the FY2017 annual figure was $14.1 million, down 63.45% from the prior year.
• Short-term Investments slipped to $2.0 million in Q1 2018 per DCOY's latest filing, from $14.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $39.5 million in Q3 2016 and bottomed at $2.0 million in Q1 2018.
• Historically, Short-term Investments has averaged $23.1 million across 4 years, with a median of $24.7 million in 2015.
• Annual changes were most pronounced in 2016 — Short-term Investments surged 295.06% — and 2018, when it tumbled 93.7%.
• Decoy Therapeutics' Short-term Investments stood at $24.7 million in 2015, then jumped by 56.82% to $38.7 million in 2016, then sank by 63.45% to $14.1 million in 2017, then slumped by 85.85% to $2.0 million in 2018.
• Business Quant data shows DCOY's Short-term Investments at $2.0 million in Q1 2018, $14.1 million in Q4 2017, and $18.8 million in Q3 2017.